Khalil Barrage - 25 Mar 2024 Form 4 Insider Report for Protagenic Therapeutics, Inc.\new (PTIX)

Role
Director
Signature
/s/ Alexander Arrow, as attorney-in-fact
Issuer symbol
PTIX
Transactions as of
25 Mar 2024
Net transactions value
+$39,150
Form type
4
Filing time
29 Mar 2024, 21:29:19 UTC
Previous filing
01 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTIX PTIX Common stock Options Award $39,150 +22,500 $1.74 22,500 25 Mar 2024 PTIX common stock, Par Value $0.0001 22,500 $1.74 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

The options vest monthly over 24 months, commencing upon the date of grant, with full acceleration upon a change of control.